{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:12:23Z","timestamp":1792717943631,"version":"4.5.0"},"reference-count":49,"publisher":"Portland Press Ltd.","issue":"4","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,8,1]]},"abstract":"<jats:p>Inflammation has long been proposed as having a role in AD (Alzheimer's disease), although it remains unclear whether inflammation represents a cause or consequence of AD. Evidence from the clinical setting in support of a role for inflammation in AD includes increased expression of inflammatory mediators and microglial activation in the post-mortem AD brain. Also, epidemiological studies on AD patients under long-term treatment with non-steroidal anti-inflammatory drugs suggest some benefits, although recent prospective trials showed no effect. Furthermore, in AD patients, infection and other systemic inflammatory events worsen symptoms. Finally, several inflammatory genes are associated with increased risk of AD. Therefore, to elucidate the underlying mechanisms of AD and the role of inflammation, researchers have turned to experimental models and here we present a short overview of some key findings from these studies. Activation of microglia is seen in various transgenic models of AD, with both a protective role and a detrimental role being ascribed to it. Early microglial activation is probably beneficial in AD, through phagocytosis of amyloid \u03b2-peptide. At later stages however, pro-inflammatory cytokine release from microglia could contribute to neuronal demise. A better understanding of microglial phenotype at the various stages of AD is therefore still required. Although most studies suggest a detrimental role for pro-inflammatory cytokines such as interleukin-1 and tumour necrosis factor in AD, contradictory findings do exist. Age-related and differential cellular expression of these inflammatory mediators is probably a key determinant of their exact contribution to AD. In conclusion, there is no doubt that inflammatory processes are part of the pathophysiology of AD, but a better understanding of the exact contribution at different stages of the disease process is still required before appropriate treatment strategies can be devised.<\/jats:p>","DOI":"10.1042\/bst0390886","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T12:05:03Z","timestamp":1311681903000},"page":"886-890","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Assessing the contribution of inflammation in models of Alzheimer's disease"],"prefix":"10.1042","volume":"39","author":[{"given":"Hannah","family":"Johnston","sequence":"first","affiliation":[{"name":"Faculty of Life Sciences, University of Manchester, AV Hill Building, Manchester M13 9PT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herve","family":"Boutin","sequence":"additional","affiliation":[{"name":"Faculty of Life Sciences, University of Manchester, AV Hill Building, Manchester M13 9PT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart\u00a0M.","family":"Allan","sequence":"additional","affiliation":[{"name":"Faculty of Life Sciences, University of Manchester, AV Hill Building, Manchester M13 9PT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2011,7,20]]},"reference":[{"key":"2021111719452858300_B1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"2021111719452858300_B2","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Arch. Neurol."},{"key":"2021111719452858300_B3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of A\u03b242 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"2021111719452858300_B4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1326-4-47","article-title":"Does neuroinflammation fan the flame in neurodegenerative diseases?","volume":"4","author":"Frank-Cannon","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"2021111719452858300_B5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/187152710791012026","article-title":"Non-steroidal anti-inflammatory drugs and Alzheimer's disease: the epidemiological evidence","volume":"9","author":"Szekely","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"2021111719452858300_B6","article-title":"Alzheimer's disease genetics: current knowledge and future challenges","author":"Hollingworth","year":"2010","journal-title":"Int. J. Geriatr. Psychiatr."},{"key":"2021111719452858300_B7","first-page":"1005","article-title":"Inflammation in Alzheimer disease: driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat. Med."},{"key":"2021111719452858300_B8","doi-asserted-by":"crossref","first-page":"e00019","DOI":"10.1042\/AN20090042","article-title":"Animal models for Alzheimer's disease and frontotemporal dementia: a perspective","volume":"1","author":"Gotz","year":"2009","journal-title":"ASN NEURO"},{"key":"2021111719452858300_B9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.tins.2010.05.004","article-title":"\u2018Too much good news\u2019: are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease?","volume":"33","author":"Zahs","year":"2010","journal-title":"Trends Neurosci."},{"key":"2021111719452858300_B10","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1098\/rstb.2003.1358","article-title":"Inflammation in central nervous system injury","volume":"358","author":"Allan","year":"2003","journal-title":"Philos. Trans. R. Soc. London Ser. B"},{"key":"2021111719452858300_B11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/JAD-2010-1349","article-title":"A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-\u03b2-associated cognitive impairment","volume":"20","author":"Leon","year":"2010","journal-title":"J. Alzheimer's Dis."},{"key":"2021111719452858300_B12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1742-2094-7-64","article-title":"Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease","volume":"7","author":"Stozicka","year":"2010","journal-title":"J. Neuroinflamm."},{"key":"2021111719452858300_B13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(02)00888-1","article-title":"Pathological relationships between microglial cell activity and tau and amyloid \u03b2 protein in patients with Alzheimer's disease","volume":"331","author":"Hayes","year":"2002","journal-title":"Neurosci. Lett."},{"key":"2021111719452858300_B14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(01)05625-2","article-title":"In-vivo measurement of activated microglia in dementia","volume":"358","author":"Cagnin","year":"2001","journal-title":"Lancet"},{"key":"2021111719452858300_B15","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00702-010-0438-z","article-title":"Neuroinflammatory processes in Alzheimer's disease","volume":"117","author":"Heneka","year":"2010","journal-title":"J. Neural Transm."},{"key":"2021111719452858300_B16","doi-asserted-by":"crossref","first-page":"10957","DOI":"10.1523\/JNEUROSCI.0673-07.2007","article-title":"Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography","volume":"27","author":"Maeda","year":"2007","journal-title":"J. Neurosci."},{"key":"2021111719452858300_B17","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: active sensor and versatile effector cells in the normal and pathologic brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat. Neurosci."},{"key":"2021111719452858300_B18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","article-title":"Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease","volume":"118","author":"Streit","year":"2009","journal-title":"Acta Neuropathol."},{"key":"2021111719452858300_B19","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/brain\/awn331","article-title":"Powerful beneficial effects of macrophage colony-stimulating factor on \u03b2-amyloid deposition and cognitive impairment in Alzheimer's disease","volume":"132","author":"Boissonneault","year":"2009","journal-title":"Brain"},{"key":"2021111719452858300_B20","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1074\/jbc.M508125200","article-title":"Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid \u03b2 peptide","volume":"281","author":"Chen","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2021111719452858300_B21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000095638","article-title":"It may take inflammation, phosphorylation and ubiquitination to \u2018tangle\u2019 in Alzheimer's disease","volume":"3","author":"Arnaud","year":"2006","journal-title":"Neurodegener. Dis."},{"key":"2021111719452858300_B22","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","article-title":"Microglial dysfunction and defective \u03b2-amyloid clearance pathways in aging Alzheimer's disease mice","volume":"28","author":"Hickman","year":"2008","journal-title":"J. Neurosci."},{"key":"2021111719452858300_B23","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer disease","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurology"},{"key":"2021111719452858300_B24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nri2015","article-title":"Systemic infections and inflammation affect chronic neurodegeneration","volume":"7","author":"Perry","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"2021111719452858300_B25","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"2021111719452858300_B26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","article-title":"Regulation of tau pathology by the microglial fractalkine receptor","volume":"68","author":"Bhaskar","year":"2010","journal-title":"Neuron"},{"key":"2021111719452858300_B27","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2353\/ajpath.2010.100265","article-title":"CX3CR1 deficiency alters microglial activation and reduces \u03b2-amyloid deposition in two Alzheimer's disease mouse models","volume":"177","author":"Lee","year":"2010","journal-title":"Am. J. Pathol."},{"key":"2021111719452858300_B28","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1523\/JNEUROSCI.2868-05.2005","article-title":"Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease","volume":"25","author":"Kitazawa","year":"2005","journal-title":"J. Neurosci."},{"key":"2021111719452858300_B29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1742-2094-7-56","article-title":"LPS-induced inflammation exacerbates phospho-tau pathology in rTg4510 mice","volume":"7","author":"Lee","year":"2010","journal-title":"J. Neuroinflamm."},{"key":"2021111719452858300_B30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.expneurol.2004.07.007","article-title":"Time-dependent reduction in A\u03b2 levels after intracranial LPS administration in APP transgenic mice","volume":"190","author":"Herber","year":"2004","journal-title":"Exp. Neurol."},{"key":"2021111719452858300_B31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1742-2094-5-37","article-title":"Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of \u03b2-amyloid generation","volume":"5","author":"Lee","year":"2008","journal-title":"J. Neuroinflamm."},{"key":"2021111719452858300_B32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.jnen.0000178444.33972.e0","article-title":"Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics","volume":"64","author":"Morgan","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2021111719452858300_B33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1189\/jlb.72.2.233","article-title":"Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease","volume":"72","author":"Griffin","year":"2002","journal-title":"J. Leukocyte Biol."},{"key":"2021111719452858300_B34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-2-15","article-title":"Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human \u03b2-amyloid","volume":"2","author":"Craft","year":"2005","journal-title":"J. Neuroinflamm."},{"key":"2021111719452858300_B35","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1172\/JCI31450","article-title":"Sustained hippocampal IL-1\u03b2 overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology","volume":"117","author":"Shaftel","year":"2007","journal-title":"J. Clin. Invest."},{"key":"2021111719452858300_B36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbi.2010.10.015","article-title":"Immune modulation of learning, memory, neural plasticity and neurogenesis","volume":"25","author":"Yirmiya","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"2021111719452858300_B37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nri1664","article-title":"Interleukin-1 and neuronal injury","volume":"5","author":"Allan","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"2021111719452858300_B38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-5-7","article-title":"The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective","volume":"5","author":"Shaftel","year":"2008","journal-title":"J. Neuroinflamm."},{"key":"2021111719452858300_B39","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.4049\/jimmunol.0903382","article-title":"IFN-\u03b3 promotes complement expression and attenuates amyloid plaque deposition in amyloid \u03b2 precursor protein transgenic mice","volume":"184","author":"Chakrabarty","year":"2010","journal-title":"J. Immunol."},{"key":"2021111719452858300_B40","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2353\/ajpath.2007.060378","article-title":"Interferon-gamma and tumor necrosis factor-\u03b1 regulate amyloid-\u03b2 plaque deposition and \u03b2-secretase expression in Swedish mutant APP transgenic mice","volume":"170","author":"Yamamoto","year":"2007","journal-title":"Am. J. Pathol."},{"key":"2021111719452858300_B41","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.2353\/ajpath.2008.080528","article-title":"Chronic neuron-specific tumor necrosis factor-\u03b1 expression enhances the local inflammatory environment ultimately leading to neuronal death in 3\u00d7Tg-AD mice","volume":"173","author":"Janelsins","year":"2008","journal-title":"Am. J. Pathol."},{"key":"2021111719452858300_B42","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1083\/jcb.200705042","article-title":"Deletion of tumor necrosis factor death receptor inhibits amyloid \u03b2 generation and prevents learning and memory deficits in Alzheimer's mice","volume":"178","author":"He","year":"2007","journal-title":"J. Cell Biol."},{"key":"2021111719452858300_B43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.brainres.2010.10.053","article-title":"Anti-TNF-\u03b1 reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP\/PS1 transgenic mouse brains","volume":"1368","author":"Shi","year":"2011","journal-title":"Brain Res."},{"key":"2021111719452858300_B44","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1096\/fj.09-141754","article-title":"Massive gliosis induced by interleukin-6 suppresses A\u03b2 deposition in vivo: evidence against inflammation as a driving force for amyloid deposition","volume":"24","author":"Chakrabarty","year":"2010","journal-title":"FASEB J."},{"key":"2021111719452858300_B45","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1073\/pnas.94.4.1500","article-title":"Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain","volume":"94","author":"Heyser","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719452858300_B46","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1460-9568.2007.05652.x","article-title":"Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model","volume":"26","author":"Butovsky","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"2021111719452858300_B47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","article-title":"Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease","volume":"49","author":"Simard","year":"2006","journal-title":"Neuron"},{"key":"2021111719452858300_B48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.mp.4001809","article-title":"Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease","volume":"11","author":"Simard","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"2021111719452858300_B49","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/156720511795256062","article-title":"Inflammatory risk factors and pathologies associated with Alzheimer's disease","volume":"8","author":"Sastre","year":"2011","journal-title":"Curr. Alzheimer Res."}],"container-title":["Biochemical Society Transactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/39\/4\/886\/548947\/bst0390886.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/39\/4\/886\/548947\/bst0390886.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T09:56:53Z","timestamp":1686218213000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article\/39\/4\/886\/65266\/Assessing-the-contribution-of-inflammation-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,20]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,7,20]]},"published-print":{"date-parts":[[2011,8,1]]}},"URL":"https:\/\/doi.org\/10.1042\/bst0390886","relation":{},"ISSN":["0300-5127","1470-8752"],"issn-type":[{"value":"0300-5127","type":"print"},{"value":"1470-8752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,20]]}}}